Group 1 - The core viewpoint of the report highlights that the Beijing Stock Exchange (BSE) has reached a milestone of 300 listed companies, with over 55% being "little giants" and 65 single champions, establishing a strong foundation for new productive forces [2][11][18] - The BSE has shown a steady increase in the number of specialized and innovative small and medium-sized enterprises, with the proportion of national-level "little giants" rising from 44% to 55.33% as the number of such companies grew from 44 to 99 [2][18][19] - The report indicates that the 300 listed companies are primarily concentrated in advanced manufacturing and strategic emerging industries, which are crucial for enhancing the capital market's role in empowering new productive forces and addressing supply chain deficiencies [2][28] Group 2 - The report notes that the average and median revenue for companies queued for listing in 2024 are projected to be 791 million and 588 million respectively, indicating a high-quality pipeline of future listings [2][39] - The distribution of companies by revenue shows that 32.85% of the queued companies are expected to generate revenue between 5-10 billion, while 25.12% are anticipated to exceed 10 billion [29][31] - The report emphasizes that the BSE's focus on "specialized, refined, unique, and innovative" enterprises is creating a market ecosystem that supports the growth of these companies, which are characterized by their unique products and advanced technologies [15][18] Group 3 - The report highlights that the BSE's market performance has been affected by rising risk premiums, with the North Certificate 50 and specialized new index experiencing declines of 5.76% and 7.57% respectively [3][57] - The valuation metrics for various sectors indicate that high-end equipment, chemical new materials, and biomedicine have significant valuation advantages compared to information technology, with respective P/E ratios of 36.58X, 44.08X, and 32.34X [3][65] - The report suggests that the BSE is positioned to enhance its market appeal by attracting high-quality specialized and innovative enterprises, particularly in sectors that are currently underrepresented compared to other boards like the Sci-Tech Innovation Board and the Growth Enterprise Market [45][49]

Group 1: New Companies Listed - Five new companies were listed this week, with a focus on BeiBian Technology and XinYuan Technology, among others. The average revenue for 2024 is projected to be 249 million yuan, with a median of 188 million yuan. The average net profit is estimated at 41.1 million yuan, with a median of 46.7 million yuan [2][13]. Group 2: BeiBian Technology - BeiBian Technology specializes in phase-shifting rectifier transformers for data centers, which are expected to enter the supply chain of major manufacturers by 2024. The market for phase-shifting rectifiers in China is projected to grow from 2.916 billion yuan in 2023 to 4.788 billion yuan by 2030, with a compound annual growth rate of 7.34% [3][21]. - The company is actively developing solid-state transformers (SST) to meet future demands in data centers and power supply systems [15][24]. Group 3: XinYuan Technology - XinYuan Technology is a manufacturer of bipolar plates for flow batteries, with a market share of 19.41% in 2023 and 27.39% in 2024. The revenue from flow battery bipolar plates is projected to be 4.6178 million yuan in 2023 and 36.9605 million yuan in 2024 [4][42]. - The domestic market for flow battery bipolar plates is expected to reach 1.26 billion yuan by 2026, with a significant increase in installed capacity anticipated [39][37]. Group 4: Market Dynamics - The total market capitalization of companies listed on the New Third Board reached 25,856.35 billion yuan as of February 28, 2026, reflecting a 13.17 billion yuan increase [5][11]. - The New Third Board has cumulatively facilitated the listing of 873 companies, contributing to the multi-tiered capital market structure in China [2][15]. Group 5: Industry Trends - The transition from UPS systems to high-voltage direct current (HVDC) technology in data centers is gaining momentum, driven by the need for efficiency and cost reduction [21][22]. - The liquid flow battery market is experiencing rapid growth, with a projected compound annual growth rate of 1,462.50% from 2023 to 2026, indicating a strong demand for long-duration energy storage solutions [36][37].

Market Overview - The A-share market is currently confirming expectation discrepancies amid escalating geopolitical tensions in the Middle East, with the Shanghai Composite Index dropping by 3.38% this week[13] - Daily trading volume averaged 2.21 trillion yuan, a decrease of approximately 287.6 billion yuan compared to the previous week[13] Historical Resilience - Since 2020, A-shares have shown strong resilience against global shocks, with negative impacts typically concluding within a week[19] - Historical data indicates that after significant external shocks, A-share indices have generally recovered to pre-shock levels within one month, with a recovery probability of approximately 68.8% since 2020[24] Investment Strategy - During periods of external shocks, it is advisable to reduce positions and manage risks, with a focus on cash holdings to capture excess returns when market conditions stabilize[19] - In the rebound phase, sectors with strong policy support and supply-demand dynamics are expected to outperform, particularly in energy security and AI-related industries[6] Sector Allocation - Dividend-paying stocks are favored during adjustment periods, although they are not absolute safe havens; they still exhibit risk characteristics[27] - Key sectors during the current geopolitical tensions include coal, photovoltaic, hydropower, and energy storage, which are expected to benefit from rising industrial demand[33] Risk Considerations - Potential risks include unexpected macroeconomic policy changes and escalations in geopolitical tensions, which could impact market stability[44]

Group 1 - The report highlights that the ongoing geopolitical tensions in the Middle East are causing a significant increase in fertilizer prices, which is expected to boost demand for Chinese fertilizers during the spring farming season [3][12][17] - Urea prices have surged approximately 30% within a week, reaching the highest level since 2022, while domestic production capacity remains sufficient, leading to a relatively stable price increase in China [3][17] - The report identifies key companies in the agricultural chemical sector on the Beijing Stock Exchange, including Ying Tai Biological, Nongda Technology, and Deer Chemical, which are positioned to benefit from rising agricultural input prices and increasing international grain prices [4][25] Group 2 - The report notes a 7.70% decline in the chemical new materials sector on the Beijing Stock Exchange, with all sub-sectors experiencing downturns, including battery materials and chemical products [5][33][34] - Specific companies such as Tian Gong Co. and Ge Bi Jia have shown varied performance, with Tian Gong Co. increasing by 3.84% while others like Jilin Carbon Valley and Guo Liang New Materials faced declines [35][38] - The report provides insights into the price trends of various chemical products, indicating fluctuations in prices for raw materials like MDI and TDI, as well as agricultural chemicals like glyphosate, which has risen to 28,500 yuan per ton [39][40][41] Group 3 - The report discusses the financial performance of companies like Minshida and Kexin New Materials, with Minshida reporting a 26.7% increase in net profit for 2025, driven by strong demand in the electric transformer and AI data center sectors [6][80] - Kexin New Materials also reported a significant increase in revenue and net profit, highlighting the importance of technological innovation and environmental upgrades in a competitive market [6][80] - The report emphasizes the potential for agricultural companies to capitalize on rising prices for fertilizers and pesticides, suggesting a favorable outlook for the agricultural chemical industry [4][25][24]

Group 1 - The report highlights the launch of hydrogen energy comprehensive application pilot projects by three government departments, which is expected to benefit 16 listed companies in the North Exchange involved in fuel cells and hydrogen metallurgy [4][14][17] - The pilot projects aim to explore commercial applications of hydrogen energy across various sectors, including fuel cell vehicles, green ammonia, hydrogen metallurgy, and hydrogen blending combustion [15][16] - By 2030, the goal is to achieve large-scale applications of hydrogen energy in multiple fields, with the average terminal hydrogen price dropping below 25 yuan per kilogram [14] Group 2 - The North Exchange's high-end equipment sector experienced an average decline of 7.34% in stock prices over the past week, with the median P/E ratio dropping to 41.7X [5][26] - The technology sector saw a median P/E ratio decrease from 48.9X to 45.5X, with an overall market capitalization decline from 501.82 billion to 465.64 billion yuan [6][49] - The automotive sector's median P/E ratio fell to 26.4X, reflecting a challenging market environment [63] Group 3 - The report emphasizes the importance of annual report disclosures, highlighting companies with high growth potential, such as Haineng Technology, which reported a 16.63% increase in revenue and a 222.3% increase in net profit [7][70] - Other companies like Minshida and Xingtou Measurement Control also reported significant revenue growth, indicating a positive trend in their financial performance [7][70]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights the launch of JD's cross-border e-commerce platform Joybuy in six European countries, marking a shift to comprehensive retail operations and emphasizing a self-operated model to enhance competitive differentiation [25][27] - The report suggests focusing on high-quality companies in sectors benefiting from emotional consumption themes, including gold jewelry, offline retail, cosmetics, and medical aesthetics [7][30][31] Industry Overview - The retail and social service indices reported a decline of 4.55% and 4.00% respectively during the week of March 16-20, 2026, with the retail index down 12.57% year-to-date [6][15] - The hotel and restaurant sector showed the smallest decline this week, while it has the highest growth year-to-date at 3.19% [18][20] Company-Specific Insights - Joybuy's self-operated model is expected to create a competitive edge through quality control and service reliability, with over 60 logistics warehouses established in Europe [27][28] - The report recommends several companies based on their growth potential: - **Old Puhuang**: Expected net profit growth of 226%-233% in 2025, driven by channel expansion and brand enhancement [32][41] - **Chao Hong Ji**: Anticipated net profit growth of 125%-175% in 2025, supported by differentiated product strength and multi-channel marketing [35] - **Mao Ge Ping**: Expected revenue growth of 31.3% in H1 2025, benefiting from its position as a high-end domestic cosmetics brand [35] - **Meili Tianyuan Medical Health**: Projected net profit growth of 34% in 2025, leveraging strong market positioning in high-end beauty [35] Market Dynamics - The report emphasizes the importance of adapting to consumer trends, with a focus on emotional value and innovative product safety in cosmetics and personal care [30][31] - Companies are encouraged to explore opportunities in the evolving landscape of cross-border e-commerce, particularly those with strong brand and supply chain capabilities [27][30]

Investment Rating - The industry investment rating is "Overweight" (maintained) [1] Core Viewpoints - The report indicates that low valuations are expected to provide anti-drawdown characteristics, with a focus on performance and style switching catalysts [4] - The insurance and brokerage sectors continue to adjust due to geopolitical conflicts, but the medium-term logic remains unchanged, with positive trends in non-bank business and asset sides driven by deposit migration and a slow bull market [4] - The report highlights that the valuation of five A-share insurance companies has dropped to a low of 0.73 times P/EV, while leading brokerages have PB and PE valuations at historical lows, suggesting potential for anti-drawdown characteristics and left-side opportunities [4] Summary by Sections Brokerage - The average daily trading volume of stock-based funds is 2.74 trillion, down 10% week-on-week; however, the cumulative average daily trading volume for the year is 3.22 billion, up 85% year-on-year [5] - Six brokerages have initiated consolidated regulatory reporting, with a deadline for submitting 2025 annual reports by April 30, 2026 [5] - The report recommends the brokerage sector, focusing on low-valuation firms with high wealth management contributions, such as Huatai Securities and GF Securities, as well as leading brokerages like Guotai Junan and CITIC Securities [5] Insurance - Sunshine Insurance reported a total premium income of 150.72 billion, up 17.4% year-on-year, with a net profit of 6.31 billion, up 15.7% [6] - The self-pricing coefficient for new energy vehicle insurance has been optimized, which is expected to benefit market pricing and the development of new energy vehicle insurance business [6] - The report recommends China Pacific Insurance, China Life H shares, and Ping An, highlighting the high growth potential in the liability side due to deposit migration [6] Recommended and Beneficiary Stocks - Recommended stock combination includes Huatai Securities, Guotai Junan, China Pacific Insurance, Tonghuashun, China Life, Ping An, GF Securities, CITIC Securities, and others [7]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights the acceleration of domestic innovation in the pharmaceutical and biotechnology sector, showcasing a shift from "follow" to "first" in local innovation, particularly in areas such as second-generation immune combination therapies, single/double antibody ADCs, and AI-assisted diagnostics [5][14][15] - The report emphasizes significant survival benefits from ADC drugs in the treatment of EGFRm NSCLC and SCLC, indicating a paradigm shift in treatment approaches [6][21] Summary by Sections 1. Domestic Leadership in ADC Era - ELCC 2026 will focus on key areas such as second-generation immune combination therapies and targeted therapies for KRAS/HER2/EGFR [5][14] - Notable studies presented at ELCC 2026 include sac-TMT (Trop2 ADC) by Kelun-Biotech and Iza-bren (EGFR/HER3 ADC) by BaiLi Tianheng, among others [15][16] 2. Market Performance - The pharmaceutical and biotechnology sector experienced a decline of 2.77% in March, underperforming the CSI 300 index by 0.59 percentage points [24][27] - Among sub-sectors, the in vitro diagnostics segment had the smallest decline, while the hospital sector faced the largest drop [27][28] 3. Recommended Stocks - Monthly recommended stocks include WuXi AppTec, CSPC Pharmaceutical, Innovent Biologics, BaiLi Tianheng, and others [8] - Weekly recommended stocks include HengRui Medicine, Kelun-Biotech, and others [8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][3] Core Insights - The company has reported a significant increase in revenue and net profit, with new contract signings showing a year-on-year growth of 107% [3][5] - The engineering construction business has seen a decline in gross margin, leading to a downward adjustment in profit forecasts for 2026-2028 [3][4] - The company is expected to benefit from complementary advantages with its controlling shareholder, which may drive continued revenue growth [3] Financial Performance - In 2025, the company achieved total operating revenue of 76.35 billion yuan, a year-on-year increase of 15.53%, and a net profit attributable to shareholders of 1.09 billion yuan, up 14.21% [4] - The gross margin for 2025 was 5.25%, a decrease of 0.70 percentage points year-on-year, while the net profit margin was 1.75%, down 0.11 percentage points [4] - The company plans to distribute a cash dividend of 0.15 yuan per share, totaling 0.39 billion yuan, which represents approximately 35.8% of the net profit attributable to shareholders [4] Business Structure - The construction business generated revenue of 66.75 billion yuan in 2025, accounting for 87.4% of total revenue, with a year-on-year growth of 17.15% [5] - The surveying and design business contributed 4.38 billion yuan, representing 5.7% of total revenue, with a year-on-year increase of 9.19% [5] - The company successfully entered the Thai market in 2025, securing three projects with a total contract value exceeding 16 million yuan [5] Profit Forecasts - The projected net profits for 2026, 2027, and 2028 are 1.3 billion yuan, 1.5 billion yuan, and 1.7 billion yuan, respectively, with corresponding EPS of 0.48 yuan, 0.58 yuan, and 0.66 yuan [3][6] - The current price-to-earnings (P/E) ratios for 2026, 2027, and 2028 are estimated at 22.5, 19.0, and 16.6 times, respectively [3][6]

Group 1 - The market is still confirming the expectation gap regarding the ongoing Middle East conflict, which has expanded in intensity and scope, affecting energy facilities, shipping, and regional political structures [4][13][14] - Since 2020, A-shares have shown resilience against global public events, with negative impacts typically concluding within a week. During prolonged shocks, the strategy should focus on reducing positions and controlling risks [19][20] - The next significant signal for market recovery is expected to be the convergence of oil price volatility rather than the final price level itself [23][24] Group 2 - In the adjustment phase, dividend stocks are favored, particularly during the late stages of a bear market, where their relative return advantages are amplified. However, dividend assets remain risk assets and may not provide absolute returns [6][27] - Industry performance during external shocks has shown that sectors with independent industrial prosperity perform best. For instance, during the Ukraine conflict, sectors like pharmaceuticals and energy security (coal) excelled, and similar trends are expected in the current Middle East situation [6][32][33] - The investment strategy emphasizes a defensive approach before the next major signal appears, focusing on high-dividend stocks and sectors benefiting from rising industrial demand and energy security [44] Group 3 - Historical analysis indicates that A-shares have become more resilient to external shocks since 2020, with a significant reduction in the duration and magnitude of declines during such events [22][24] - The probability of index recovery after external shocks has increased, with most indices recovering to pre-shock levels within one month, particularly in the current bull market context [25][24] - The report suggests that the current geopolitical risks primarily affect China indirectly, with manageable energy dependencies and a supportive regulatory environment aiding market stability [42][43]